Fulgent Genetics Inc. (NASDAQ: FLGT) started the day on April 07, 2021, with a price decrease of -8.03% at $85.60. During the day, the stock rose to $92.1399 and sunk to $84.189 before settling in for the price of $93.07 at the close. Taking a more long-term approach, FLGT posted a 52-week range of $8.90-$189.89.
It was noted that the giant of the Healthcare sector posted annual sales growth of 113.20% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 89.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.90%. This publicly-traded company’s shares outstanding now amounts to $25.40 million, simultaneously with a float of $14.29 million. The organization now has a market capitalization sitting at $2.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $113.11, while the 200-day Moving Average is $57.33.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 429 workers. It has generated 983,012 per worker during the last fiscal year. Meanwhile, its income per employee was 509,706. The stock had 3.99 Receivables turnover and 1.06 Total Asset turnover. For the Profitability, stocks gross margin was +78.70, operating margin was +68.80 and Pretax Margin of +69.17.
Fulgent Genetics Inc. (FLGT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Fulgent Genetics Inc.’s current insider ownership accounts for 31.90%, in contrast to 34.70% institutional ownership. According to the most recent insider trade that took place on Mar 15, this organization’s Chief Operating Officer sold 3,000 shares at the rate of 104.10, making the entire transaction reach 312,300 in total value, affecting insider ownership by 342,476. Preceding that transaction, on Mar 09, Company’s Chief Operating Officer sold 62,000 for 102.65, making the whole transaction’s value amount to 6,364,219. This particular insider is now the holder of 345,476 in total.
Fulgent Genetics Inc. (FLGT) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported $6.2 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $4.05) by $2.15. This company achieved a net margin of +51.85 while generating a return on equity of 67.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.61 per share during the current fiscal year.
Fulgent Genetics Inc.’s EPS increase for this current 12-month fiscal period is 36.90% and is forecasted to reach 3.74 in the upcoming year.
Fulgent Genetics Inc. (NASDAQ: FLGT) Trading Performance Indicators
Let’s observe the current performance indicators for Fulgent Genetics Inc. (FLGT). It’s Quick Ratio in the last reported quarter now stands at 4.00. The Stock has managed to achieve an average true range (ATR) of 11.34. Alongside those numbers, its PE Ratio stands at $10.19, and its Beta score is 1.62. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.64. Similarly, its price to free cash flow for trailing twelve months is now 22.53.
In the same vein, FLGT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 8.40, a figure that is expected to reach 5.98 in the next quarter, and analysts are predicting that it will be 3.74 at the market close of one year from today.
Technical Analysis of Fulgent Genetics Inc. (FLGT)
If we take a close look at the recent performances of Fulgent Genetics Inc. (NASDAQ: FLGT), its last 5-days Average volume was 1.24 million that shows plunge from its year to date volume of 2.11 million. During the previous 9 days, stock’s Stochastic %D was recorded 16.89% While, its Average True Range was 10.17.
Raw Stochastic average of Fulgent Genetics Inc. (FLGT) in the period of the previous 100 days is set at 33.95%, which indicates a major rise in contrast to 3.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 86.31% that was lower than 130.92% volatility it exhibited in the past 100-days period.